Kengo Tsukahara
Overview
Explore the profile of Kengo Tsukahara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
954
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamashita Y, Morimoto T, Muraoka N, Shioyama W, Chatani R, Shibata T, et al.
Circulation
. 2024 Nov;
151(9):589-600.
PMID: 39556015
Background: The optimal duration of anticoagulation therapy for patients with cancer and acute low-risk pulmonary embolism (PE) is clinically relevant, but evidence is lacking. Prolonged anticoagulation therapy could have a...
2.
Fujiki S, Yamashita Y, Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, et al.
Circ J
. 2024 Sep;
PMID: 39293971
Background: The ONCO DVT study demonstrated potential benefits of extended edoxaban treatment in patients with isolated distal deep vein thrombosis in terms of thrombotic risk. However, the risk-benefit balance in...
3.
Xiong W, Yamashita Y, Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, et al.
J Thromb Haemost
. 2024 Sep;
22(12):3542-3551.
PMID: 39284385
Background: The ONCO DVT study (Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis) revealed superiority of 12-month relative to 3-month edoxaban...
4.
Yoshihara F, Matsuzawa Y, Nakatsuka K, Kirigaya J, Takeuchi I, Kimura K, et al.
Hypertens Res
. 2024 Apr;
47(7):1943-1951.
PMID: 38664510
It has not yet been established whether angiotensin II receptor blockers (ARB), statins, and multiple drugs affect the severity of COVID-19. Therefore, we herein performed an observational study on the...
5.
Chatani R, Yamashita Y, Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, et al.
Eur Heart J Cardiovasc Pharmacother
. 2024 Apr;
10(5):422-431.
PMID: 38650055
Background: The ONCO DVT study revealed the superiority of 12-month relative to 3-month edoxaban treatment for cancer-associated isolated distal deep vein thrombosis (DVT) regarding the thrombotic risk. Methods And Results:...
6.
Kikuchi S, Tsukahara K, Ichikawa S, Abe T, Nakahashi H, Minamimoto Y, et al.
J Atheroscler Thromb
. 2024 Mar;
31(9):1277-1292.
PMID: 38447974
Aims: High platelet-derived thrombogenicity during the acute phase of ST-segment elevation myocardial infarction (STEMI) is associated with poor outcomes; however, the associated factors remain unclear. This study aimed to examine...
7.
Sueta D, Yamashita Y, Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, et al.
Thromb Res
. 2024 Feb;
235:107-115.
PMID: 38335565
Background: The multicenter, open-label, randomized clinical trial ONCO DVT compared 3-month and 12-month edoxaban treatment regimens for isolated distal deep vein thrombosis (DVT) and suggested potential benefits of prolonged edoxaban...
8.
Yamashita Y, Morimoto T, Muraoka N, Oyakawa T, Umetsu M, Akamatsu D, et al.
Circulation
. 2023 Aug;
148(21):1665-1676.
PMID: 37638968
Background: The optimal duration of anticoagulation therapy for isolated distal deep vein thrombosis in patients with cancer is clinically relevant, but the evidence is lacking. The prolonged anticoagulation therapy could...
9.
Kawarada O, Zen K, Hozawa K, Obara H, Matsubara K, Yamamoto Y, et al.
J Endovasc Ther
. 2022 Nov;
31(4):622-633.
PMID: 36416475
Purpose: The underlying difference between intermittent claudication (IC) and critical limb-threatening ischemia (CLTI) still remains unclear. This prospective multicenter observational study aimed to clarify differences in clinical features and prognostic...
10.
Hayakawa A, Tsukahara K, Miyagawa S, Okajima Y, Takano K, Mitsuhashi T, et al.
J Cardiol Cases
. 2022 Jun;
25(6):404-407.
PMID: 35685265
A 78-year-old man suffering from epigastric discomfort presented with an initial electrocardiogram showing complete right bundle branch block (RBBB) and ST-segment depression continuing to positive symmetrical T waves in leads...